Response to Podophyllotoxin Treatment of Genital Warts in Relation to HIV-1 Infection among Patients in Dar Es Salaam,Tanzania

Abstract

Forty-two Tanzanian patients with genital warts were treated with 0.5% podophyllotoxin solution (Wartec) for 3 days. Thirteen patients (30.9%) were cured and a further 7 patients (16.7%) had more than 50% of lesions cleared at 6 weeks, while 19 patients were resistant to treatment. Three patients had a recurrence of lesions after an initial response. Thirty-three patients were tested for serological evidence of infection with human immunodeficiency virus (HIV) and 15 (45.5%) patients were shown to be HIV-1 antibody positive. The response to treatment was analysed in relation to HIV antibody status. The cure rate was significantly higher in HIV seronegative patients (8/18=44.4%) compared to HIV seropositive patients (1/15=6.7%) (P=0.018). We conclude that podophyllotoxin treatment provides a useful non-hospital based treatment for genital warts, but HIV infection appears to contribute to the failure of treatment for genital warts.

Keywords

Genital warts HIV podophyllotoxin Africa

Get full access to this article

View all access options for this article.

References

Kirchner

Immunobiology of human papillomavirus infection. Prog Med Virol 1986;33:1–41.

Reichman

Strike

DG.

Pathogenesis and treatment of human genital papillomavirus infection: A review. Antiviral Res 1989;11:109–18.

Syrjänen

KJ.

Epidemiology of human papilloma virus (HPV) infections and their associations with genital squamous cell cancer. APMIS 1989;97:957–70.

de Villiers

E-M

Wagner

Schneider

Human papilloma virus infections in women with and without abnormal cervical cytology. Lancet 1987;ii:703–5.

Avgerinou

Georgala

Theodoridis

Vareltzdis

Stratigos

Reduction of cell mediated immunity in patients with genital warts of long duration. Genitourin Med 1986;62:396–8.

Jablonska

Majewski

Malejczyk

HPV infection and immunological responses. In: v Krogh

Rylander

, ed. GPVI—Genital Papilloma Virus Infection—A survey for the clinician. (ISBN 91-97 13 47-0-8). Sweden: Conpharm AB 1989;289–329.

Kreiss

Carael

Meheus

Role of sexually transmitted diseases in transmitting human immunodeficiency virus. Genitourin Med 1988;64:1–2.

Byrne

Taylor-Robinson

Munday

Harris

JRW.

The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 1989;3:379–82.

Nsubuga

Mugerwa

Nsimbambi

Sweankambo

Katabira

Berkley

The association of genital ulcer disease and HIV infection at a dermatology-STD clinic in Uganda. J Acquir Immune Defic Syndr 1990;3:1002–5.

10.

Plummer

Simonsen

Cameron

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163:233–9.

11.

von Krogh

Penile condylomata acuminata: An experimental model for evaluation of topical self-treatment with 0.5–1.0% ethanolic preparations of Podophyllotoxin for three days. Sex Transm Dis 1981;8:179–86.

12.

von Krogh

Topical self-treatment of penile warts with 0.5% Podophyllotoxin in ethanol for four or five days. Sex Transm Dis 1987;14:3,135–40.

13.

Pickering

RW.

Self treatment of genital warts using warticon R (0.5% Podophyllotoxin solution). Br J Sexual Med 1989;Vol 2:302–4.

14.

von Krogh

Szpak

Andersson

Bergelin

Self treatment using 0.25%-0.5% podophyllotoxin-ethanol solutions against penile condylomata: A placebo-controlled comparative study. Genitourin Med 1994;70:105–9.